SCHEMBL3975608

SCHEMBL3975608

NC1CCCN(c2nc3ncn(Cc4ccnc5ccccc45)c(=O)c3n2Cc2ccccc2)C1

nearest known ligand 0.68

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 20/20 0.68
KCNH2 Q12809 1/20 0.55
CYP3A4 P08684 2/20 0.51
FAP Q12884 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3968666 0.90 DPP4 (0.59) DPP4CYP3A4FAP
SCHEMBL3971177 0.88 DPP4 (0.55) DPP4CYP3A4FAP
SCHEMBL3975250 0.87 DPP4 (0.58) DPP4KCNH2CYP3A4
SCHEMBL3972320 0.83 DPP4 (0.59) DPP4CYP3A4FAP
SCHEMBL3970492 0.83 DPP4 (0.56) DPP4CYP3A4FAP
SCHEMBL3969414 0.82 DPP4 (0.52) DPP4CYP3A4FAP
SCHEMBL3970690 0.81 DPP4 (0.55) DPP4FAP
SCHEMBL4225060 0.81 DPP4 (1.00) DPP4KCNH2CYP3A4
SCHEMBL4225063 0.81 DPP4 (1.00) DPP4KCNH2CYP3A4
Hydrochloric Acid SCHEMBL4221529 0.80 DPP4 (0.98) DPP4KCNH2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569574-B2 Purine derivatives, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-08-04 US disclosed
EP-1532150-B1 NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2008-06-11 EP disclosed
EP-1532150-A1 NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-05-25 EP disclosed
WO-2004018469-A1 NOVEL PURINE DERIVATIVES, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-03-04 WO disclosed